APOPTOSIS INDUCER SET

APOPTOSIS INDUCER SET

Stock Code: 3586634
Manufacturer Part No: APT800
Order Now for 7 day delivery
Click Add to Quote for price and delivery
Quantity: - +

Application


It is recommended to use 1000X dilutions of the supplied stocks as a starting point for inducing apoptotic activity in many cell culture systems (e.g., Add 1 µL to 1 mL culture medium), however, the optimal doses may vary for different cell and culture conditions. For small volumes diluting the stocks 1:10 into fresh DMSO, then diluting the material further 1:100 into the culture media or PBS can facilitate the addition of the inhibitor to small volumes of less than 1 mL.


Research CategoryApoptosis & Cancer


Components


⋅ Actinomycin D (10 mM): 50 µL⋅ Camptothecin (2 mM): 1 mL⋅ Cycloheximide (100 mM): 1 mL⋅ Dexamethasone (10 mM): 1 mL⋅ Etoposide (10 mM): 100 µL


Disclaimer


Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


General description


Actinomycin D: Classical anti-neoplastic drug. Cytotoxic inducer of apoptosis against tumor cells. A DNA dependent inhibitor of RNA synthesis, actinomycin promotes induction of apoptosis by some specific stimuli, for example, TRAIL and Fas (CD95). Actinomycin D can also alleviate or block the apoptotic process and decrease the cytotoxicity induced by several stimuli such as the dihydrofolate reductase inhibitor aminopterin and the prostaglandin derivative 15-deoxy-D12,14-prostaglandin J2, thus it can have both pro and ant-apoptotic activities in some systems.



Camptothecin: Powerful anti-tumor agent. Camptoethecin is an inhibitor of DNA-topoisomerase I. The drug activates the p53 resulting in upregulated expression of TRAIL-R2 (DR5) and Bak to overcome TRAIL resistance in Bax-deficient human colon carcinoma cancer cells. In addition, Camptoethecin induced apoptosis can be increased by the presence of cytokines such as TNF via its subsequent inhibition of NFkappa B {Valente P et al Eur J Cancer (2003) 39:1468-77}.



Cycloheximide: A potent protein translation inhibitor which results in the inhibition of protein synthesis and subsequent arrest of cell growth and induction of cell death. Cycloheximide also facilitates apoptosis induction via FasL, however, cycloheximide can also prevent apoptosis in some systems, such as thalassemic serum induction of HUVEC cells {Banjerdpong, R. (1998) Ph.D Thesis Mahidol Univ. Bangkok, Thailand}.



Dexamethasone: Classic inducer of apoptosis in thymocytes; a glucocorticoid anti-inflammatory agent. Regulates T cell survival, growth and differientiation; modulator of nitric oxide synthase. Induces apoptosis in thymocytes as well as other immune cells like microglia. However, like other apoptotic inducers, dexamethasone can suppress apoptosis in certain systems through the activation of anti-apoptotic proteins such as bcl-X {Chang, et al (1997) FEBS Letter 415:11-15}.



Etoposide: Potent topoisomerase II inhibitor. An anti-tumor agent that enhances dsDNA & ssDNA cleavage and inhibits DNA religation

Quality Level100
ManufacturerSIGMA-ALDRICH
Technique(s)activity assay: suitable
Formliquid

There are no downloads for this product.